Staphylococcus aureus produced an inhibitory factor that suppressed slime formation by Psuudomonas aeruginosa but had little effect on the growth of the organism. The inhibitory factor was not found in broth cultures but could be extracted from cultures grown on solid agar. The inhibitory factor moderately inhibited gram-negative bacteria in addition to inhibiting a variety of grampositive bacteria. The inhibitory factor was found to have a low molecular weight, as judged by its diffusibility, and it could be partially purified by gel filtration on Sephadex G-50. It was observed to be heat labile; however, its activity was stable within a wide pH range. The factor was resistant to deoxyribonuclease, ribonuclease, and lipase, but sensitive to trypsin. The role of the inhibition of slime production in pathogenicity is discussed.
Staphylococcus aureus produced an inhibitory factor that suppressed slime formation by Psuudomonas aeruginosa but had little effect on the growth of the organism. The inhibitory factor was not found in broth cultures but could be extracted from cultures grown on solid agar. The inhibitory factor moderately inhibited gram-negative bacteria in addition to inhibiting a variety of grampositive bacteria. The inhibitory factor was found to have a low molecular weight, as judged by its diffusibility, and it could be partially purified by gel filtration on Sephadex G-50. It was observed to be heat labile; however, its activity was stable within a wide pH range. The factor was resistant to deoxyribonuclease, ribonuclease, and lipase, but sensitive to trypsin. The role of the inhibition of slime production in pathogenicity is discussed.
Staphylococcus aureus and Pseudomonas aeruginosa, in addition to having different properties, are known to be opportunistic pathogens often present in human microflora. Interactions between these two species are known to influence the evolution of infection (9, 13) . DeRepentigy et al. (3) have investigated several aspects of microbial ecology by studying the interaction between these two organisms. They reported that intraperitoneal injection of a sublethal dose of S. aureus had a protective effect against a lethal dose of P. aeruginosa. However, little is known about the interactions preceding the emergence of one of these two species infecting hosts. Bacterial interference has been recognized for over a century, and several mechanisms including pH changes, toxic metabolites, and deletion of nutrients have been postulated as the basis for this phenomenon. Production of inhibitory substance or factor(s) by several organisms is one other mechanism of bacterial interference. During slime formation studies of P. aeruginosa, it has been observed that certain S. aureus suppress slime formation by this organism without affecting growth. The Solutions of the lyophilized material (0.5 g) in 2 ml of 0.1 M phosphate buffer (pH 7) were partially purified by gel filtration in Sephadex G-50 (Pharmacia) with bed dimensions of 1.5 by 90 cm. The same buffer was used as the eluent. Fractions (2 ml) were collected at 40C and tested for protein in column effluents (expressed in terms of E280) and for inhibitory activity as described below.
Assay of inhibitory factor activity. The titer of the inhibitory factor was estimated by serially diluting the material in phosphate buffer and then spotting 0.1 ml of each dilution onto agar. After the drops had dried, the surface of each plate was exposed to chloroform vapor and was overlaid with the indicator cell (a sensitive isolate of S. aureus). The highest dilution of the inhibitory factor which inhibited growth was considered to contain 1 U of the factor per ml.
Production and isolation of slime. A broth culture of P. aeruginosa (0.1 ml) was inoculated into 100 ml of Trypticase soy broth and incubated overnight at 370C. The suspension was then shaken for a few minutes with small glass beads to separate the slime substance from the bacterial cells. The resultant slimy liquid was centrifuged at 6,000 rpm for 10 min, and the supernatant was added to two volumes of absolute ethanol. After shaking gently, the entire preparation was allowed to stand for 2 h, and the clot of slime floating on the surface was separated, washed with ethanol, and dried in vacuo.
Demonstration of slime inhibition. Two methods were employed for the demonstration of slime inhibition. In the first method, producer strains of inhibitory factor were streaked on Trypticase soy agar plates for 18 h. The plates were then exposed to chloroform vapor for 30 min, aired, and cross-streaked with P. aeruginosa. After overnight incubation, plates were screened for the inhibition of slime across the previous growth of producer strains. In the second method, the inhibitory factor (1 ml) was added to P. aeruginosa growing in broth media, and the yield of slime from each 100-ml flask was quantitatively estimated by a colorimetric method (5) .
RESULTS
The inhibitory factor was first detected in the course of slime production studies of Pseudomonas. These initial studies indicated that only 3 out of 10 strains of S. aureus produced an inhibitory factor which diffused into the agar and inhibited the slime production of Pseudomonas but not its growth. None of the S. epidermidis (10 strains) produced this factor. The inhibitory activity could easily and repeatedly be demonstrated on an agar plate (Fig. 1) gram-positive bacteria tested were susceptible except for a strain of Bacillus subtilis. Attempts were made to recover inhibitory factor from a staphylococal strain in a cell-free state with a variety of solid and liquid media. The liquid media used were brain heart infusion, Trypticase soy broth, and Todd Hewitt broth. Although the strain grew well in these media, no inhibitory activity could be detected in the supernatant fluid. The addition of ammonium sulfate produced no change. Although the inhibitory factor could not be detected in broth cultures under a variety of conditions, it could be isolated when the producer strain was inoculated onto solid medium. The possibility that a substance antagonistic to inhibitory factor activity may be produced in broth media was examined. When the inhibitory factor was incubated with broth, no decrease in its activity was observed, thus eliminating the possibility.
The lyophilized inhibitory factor was partially purified by gel filtration on a Sephadex G-50 column. The inhibitory factor was all contained in a single peak and could be easily separated (Fig. 2) . Studies on the physical characteristics of the inhibitory factor revealed that its molecular weight was sufficiently low to allow it to pass through a dialysis membrane. The factor was resistant to a variety of proteolytic enzymes (at a concentration of 1 mg/ml) including ribonuclease, deoxyribonuclease, and lipase (hog pancreas, Nutritional Biochemicals Corp.) when incubated at 37°C for 30 min. Under the same conditions, the factor was sensitive to trypsin ( at 60°C for 30 min, greater than 50% activity was lost; however, the factor remained stable for several months at 4°C. The inhibitory factor was found to be stable after exposure for 30 min to various pH's (range 2 to 10). DISCUSSION Extracellular slime is a characteristic of certain pseudomonas strains, and the formation of a complex exocellular slime has been reported in strains of P. aeruginosa under various cultural conditions. The effect of environmental conditions on the production of extracellular polysaccharide by P. aeruginosa has been investigated (14, 15) .
Staphylococci produce a wide variety of extracellular products, some of which are bactericidal against gram-positive organisms. The term bacteriocin includes inhibitory substances of a proteinaceous nature whose action is restricted to a narrow range of the same or closely related species (10) . Studies by Gagliano et al. (6) reported that two types of bacteriocins are produced by two different strains of S. aureus. One of them (staphylococci 414) is reported to be a lipoprolein complex chemically similar to membranes isolated from S. aureus.
The effects of staphylococcal extracellular product on yields of slime were examined, and it was found that slime production was inhibited. The characteristics of the factor isolated here are not shared with those of previously reported factors. P. aeruginosa was able to synthesize exopolysaccharide in the presence of various other staphylococcal products such as alphatoxin, deoxyribonuclease, and coagulase.
The specific activity of the inhibitory factor, as well as its low molecular weight, suggests that it is a microbial inhibitor other than a bacteriocin. Although the properties of this factor fit the criteria for a low-molecular-weight antibiotic (7), the possibility remains that it may be an antimetabolite. Bottone et al. (1) characterized lowmolecular-weight antibacterial substances from Streptococcus faecalis var. zymogenes. They were unable to obtain their inhibitory material in agar-free preparations but found it diffusible, sensitive to heating, and resistant to inactivation by either chloroform or trypsin.
The necessity for agar in the production of inhibitory factor suggests that it may stabilize the low molecular weight of the factor.
Although the role of both S. aureus and P. aeruginosa in producing infections has been amply verified, the interaction between these two groups of organisms is not clearly understood. Slime production by P. aeruginosa has been theorized to play a role for the invasive action of this species in the host as well as for the host immune reactions (11) . It is reasonable to assume that if S. aureus is capable of producing the inhibitory factor in vivo, colonization with such a strain may prevent the production of slime.
P. aeruginosa infections have been incriminated as a major threat to the compromised host in general and to burned patients in particular (12) . Mucoid strains of normally nonmucoid P. aeruginosa have been found in association with certain pathological conditions of humans, especially respiratory tract infections accompanying cystic fibrosis; such strains apparently may emerge in response to antibiotic treatment (4) . Studies by Kilbourn (8) have supplied evidence that S. aureus is the primary pathogen in the lungs of children with cystic fibrosis. These studies indicated that after treatment with antibiotics, Haemophilus influenzae becomes established, followed by P. aeruginosa, which at first appears as a nonmucoid strain. With continued use of antibiotics, a mucoid strain predominates.
The results of this study suggest a possible explanation for the emergence of mucoid-producing P. aeruginosa after treatment with an-VOL. 11, 1980 on August 14, 2017 by guest http://jcm.asm.org/ Downloaded from tibiotics. The antibiotics may be eliminating the staphylococci which were suppressing the production of slime by P. aeruginosa. Additional purification of the inhibitory factor isolated in this study is needed before it can be definitely identified and its mode of action can be investigated. Such studies are in progress.
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